• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Dr. Jean-Francois Geschwind

Jean-Francois H. Geschwind, MD is the new Chairman of Radiology and Biomedical Imaging at Yale School of Medicine, Radiologist in Chief at Yale-New Haven Hospital and also a Professor of Radiology and Oncology at Yale University School of Medicine.  Originally from Paris, France, Dr. Geschwind received his medical degree in 1991 from Boston University School of Medicine. He completed his residency training in Diagnostic Radiology at the University of California San Francisco and Fellowship in Vascular and Interventional Radiology in 1998 at Johns Hopkins University School of Medicine where he remained on faculty and as the Chief of Vascular and Interventional Radiology since 2002.

Dr. Geschwind is recognized as a key expert in the field of liver cancer and he has focused his research on developing new therapies for liver cancer.  He is the author or co-author of more than 400 published manuscripts and abstracts, primarily on subjects dealing with liver cancer, and is also the recipient of numerous national and international awards and grants for his research in this field.  As lead or co-investigator on more than 50 clinical trials, Dr. Geschwind’s research has been published in many top peer-reviewed journals, including the Journal of Clinical Oncology, Radiology, Hepatology, Clinical Cancer Research, Cancer Research and Annals of Surgery.

Dr. Geschwind serves on the editorial board of many journals and is a consultant to the Editor of Radiology as well as a reviewer for numerous radiology, hepatology and oncology journals.  He is the current chairman of the World Conference on Interventional Oncology Board of Directors and is the chair of the Interventional Oncology Lecture Series for the RSNA. He is a Fellow of both the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).  He is a member of the Hepatobiliary Task Force of the National Cancer Institute and an active member of the American Association for Cancer Research, the American Society of Clinical Oncology, the International Liver Cancer Association, the Radiological Society of North America, the Society of Interventional Radiology and the Cardiovascular and Interventional Radiology Society of Europe.  Dr. Geschwind is a Diplomate of the American Board of Radiology.

« Dr. Rita Nanda
Professor Ruth Plummer »

Cardiology, Diabetes & Nephrology at the Limits Canada
Wednesday, 3 & Thursday, 4 March 2021, Virtual Meeting

Cardiology, Diabetes & Nephrology at the Limits 2021
Monday, 12 & Tuesday, 13 April 2021, Virtual Meeting

The 18th Malvern Diabetic Foot Conference
Wednesday, 12 – Friday, 14 May 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info